Amicus' Crowley on Expanding Pipeline for Rare Diseases (Audio)
Jul 18, 2016
08:00
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.
